JP5753182B2 - フルオロ置換２−アリール−３，５−ジシアノ−４−インダゾリル−６−メチル−１，４−ジヒドロピリジンおよびその使用 - Google Patents

フルオロ置換２−アリール−３，５−ジシアノ−４−インダゾリル−６−メチル−１，４−ジヒドロピリジンおよびその使用 Download PDF

Info

Publication number
JP5753182B2
JP5753182B2 JP2012538292A JP2012538292A JP5753182B2 JP 5753182 B2 JP5753182 B2 JP 5753182B2 JP 2012538292 A JP2012538292 A JP 2012538292A JP 2012538292 A JP2012538292 A JP 2012538292A JP 5753182 B2 JP5753182 B2 JP 5753182B2
Authority
JP
Japan
Prior art keywords
formula
fluoro
compound
hydrogen
compound represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2012538292A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013510814A5 (enExample
JP2013510814A (ja
Inventor
アレクサンドロス・ヴァカロポウロス
マルティン・ミヒェルス
カトヤ・ツィンマーマン
ニコレ・トイシュ
マリオ・ロベル
カレン・エンゲル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Intellectual Property GmbH
Original Assignee
Bayer Intellectual Property GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Intellectual Property GmbH filed Critical Bayer Intellectual Property GmbH
Publication of JP2013510814A publication Critical patent/JP2013510814A/ja
Publication of JP2013510814A5 publication Critical patent/JP2013510814A5/ja
Application granted granted Critical
Publication of JP5753182B2 publication Critical patent/JP5753182B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2012538292A 2009-11-11 2010-11-08 フルオロ置換２−アリール−３，５−ジシアノ−４−インダゾリル−６−メチル−１，４−ジヒドロピリジンおよびその使用 Expired - Fee Related JP5753182B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09175642.9 2009-11-11
EP09175642 2009-11-11
PCT/EP2010/066983 WO2011069761A1 (en) 2009-11-11 2010-11-08 Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4-dihydropyridines and uses thereof

Publications (3)

Publication Number Publication Date
JP2013510814A JP2013510814A (ja) 2013-03-28
JP2013510814A5 JP2013510814A5 (enExample) 2014-12-25
JP5753182B2 true JP5753182B2 (ja) 2015-07-22

Family

ID=43629143

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012538292A Expired - Fee Related JP5753182B2 (ja) 2009-11-11 2010-11-08 フルオロ置換２−アリール−３，５−ジシアノ−４−インダゾリル−６−メチル−１，４−ジヒドロピリジンおよびその使用

Country Status (7)

Country Link
US (1) US9018234B2 (enExample)
EP (1) EP2499124B1 (enExample)
JP (1) JP5753182B2 (enExample)
CN (1) CN102666525B (enExample)
CA (1) CA2777907C (enExample)
ES (1) ES2549132T3 (enExample)
WO (1) WO2011069761A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104513253A (zh) 2013-10-01 2015-04-15 南京波尔泰药业科技有限公司 用于治疗增殖性疾病的大环化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3635977A (en) 1969-11-03 1972-01-18 American Cyanamid Co Certain 6-trifluoromethylcytosines and thiocytosines their synthesis and their use in the synthesis of uracisls and thiouracil
WO2005085227A1 (en) 2004-03-02 2005-09-15 Smithkline Beecham Corporation Inhibitors of akt activity
EP1828135A4 (en) 2004-12-13 2009-08-12 Irm Llc COMPOUNDS AND COMPOSITIONS AS MODULATORS OF STEROIDAL RECEPTORS AND CALCIUM CHANNEL ACTIVITIES
EP1858325A4 (en) 2005-01-07 2010-06-30 Roskamp Res Llc COMPOUNDS FOR INHIBITING BETA-AMYLOID PRODUCTION AND METHODS FOR IDENTIFYING THESE COMPOUNDS
ES2396160T3 (es) * 2006-12-14 2013-02-19 Bayer Intellectual Property Gmbh Derivados de DIHIDROPIRIDINA que utiliza como inhibidores de la proteina quinasa

Also Published As

Publication number Publication date
EP2499124B1 (en) 2015-08-19
EP2499124A1 (en) 2012-09-19
CA2777907A1 (en) 2011-06-16
CN102666525A (zh) 2012-09-12
HK1177452A1 (en) 2013-08-23
WO2011069761A1 (en) 2011-06-16
US20130005773A1 (en) 2013-01-03
JP2013510814A (ja) 2013-03-28
CA2777907C (en) 2017-08-29
ES2549132T3 (es) 2015-10-23
CN102666525B (zh) 2015-01-28
US9018234B2 (en) 2015-04-28

Similar Documents

Publication Publication Date Title
JP5753175B2 (ja) フルオロ置換３，５−ジシアノ−４−（１ｈ−インダゾール−５−イル）−２，６−ジメチル−１，４−ジヒドロピリジン誘導体およびそれらの使用方法
JP5753174B2 (ja) フッ化２，６−ジアルキル−３，５−ジシアノ−４−（１ｈ−インダゾール−５−イル）−１，４−ジヒドロピリジン類およびそれらの使用方法
JP5753182B2 (ja) フルオロ置換２−アリール−３，５−ジシアノ−４−インダゾリル−６−メチル−１，４−ジヒドロピリジンおよびその使用
JP5571800B2 (ja) フロピリジニル置換１，４−ジヒドロピリジン誘導体およびその使用方法
HK1177452B (en) Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4-dihydropyridines and uses thereof
HK1172835B (en) Fluoro-substituted 3,5-dicyano-4-(1h-indazol-5-yl)2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof
HK1172904A (en) Fluorinated 2,6-dialkyl-3,5-dicyano-4-(1h-indazol-5-yl)-1,4-dihydropyridines and methods of use thereof
HK1172904B (en) Fluorinated 2,6-dialkyl-3,5-dicyano-4-(1h-indazol-5-yl)-1,4-dihydropyridines and methods of use thereof
HK1176615A (en) Furopyridinyl-substituted 1,4-dihydropyridine derivatives and methods of use thereof

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20130319

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20131015

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20140925

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140930

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20141106

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20141215

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20150203

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150512

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150521

R150 Certificate of patent or registration of utility model

Ref document number: 5753182

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20150602

LAPS Cancellation because of no payment of annual fees